60 /100
HIGH RISK
Score updated May 30, 2026

FTHM — Fathom Holdings Inc. Dilution Risk Tracker

Track FTHM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FTHM — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
32
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
58%
🔄 Reverse Split 70%
• 50-day avg $0.79 below $1 exchange minimum
• Only 6 months cash — financial pressure
📉 Score Deterioration 50%
• Score rose 39 points recently (worsening)
• Score in HIGH risk zone (60/100)
🔁 Convertible Conversion 40%
• Significant convertible debt: 26% potential dilution
• Elevated convertible risk (60/100)
🔔 Track FTHM — Get forecast alerts →

💹 Market Data

Market Cap$18.69M
Shares Outstanding32.78M
Float23.08M
Cash$5.77M
Debt$25.65M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 8.2% shares (2025Q4 vs prior)
41 institutional holders · 3.44M shares
#1 VANGUARD GROUP INC 784.0K shares
#2 Veradace Capital Management LLC 454.4K shares
#3 Union Square Park Capital Management, LLC 381.5K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest204.9K
Days to Cover1.5
% of Float0.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Sep 30, 2024
xbrl XBRL WARRANT Jun 30, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track FTHM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FTHM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for FTHM
📊 FTHM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 FTHM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.